Widely used antidepressant outperformed by 3 other drugs in major study of 30,000 people
Three antidepressants may work better than fluoxetine, widely known by the brand name Prozac, at helping people with depression get better and stay well over time, a new study suggests.
- The company noted that fluoxetine remains available in many FDA-approved generic medicines and that neither the study nor the university’s news release specifically referred to Prozac or any Lilly product.
- The findings suggest that antidepressants can continue helping people after their symptoms improve, although some medications appeared to work better than others at keeping patients well.
- CLICK HERE FOR MORE HEALTH STORIES "Escitalopram is already widely used," he said in the release.
Researchers analyzed 115 previous clinical trials involving more than 30,000 people, according to a news release from Radboud University Medical Center in the Netherlands.
- Carole Lieberman, a board-certified psychiatrist based in Beverly Hills, California, who was not involved in the study, urged caution when interpreting the findings.
- Paul van Haaren, a researcher at Radboud University Medical Center who worked on the study, noted that the three medications have different benefits and drawbacks.
- People with questions about their antidepressants should speak with their doctor before making any medication changes, according to the release.
- Duloxetine is less well-known and is prescribed less frequently as a first-line treatment." Escitalopram belongs to a common group of antidepressants known as selective serotonin reuptake inhibitors, or SSRIs.
- TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ Psychotherapy or talk therapy can also play an important role in treating depression, according to Lieberman, while some patients may benefit from using medication along with therapy.
How this summary was made: extractive summary — built from the sources' own reporting. It is drawn only from the reporting of the sources listed below — read the originals for full detail. How we summarize →